Dr Spiegel is an Assistant Professor who joined the University of Miami in 2021 with a clinical focus on cellular therapy for hematologic malignancies. He is a translational researcher working to improve CAR-T cell outcomes for B cell malignancies and has led first in human trials of novel CAR-T therapies as well as investigator-initiated trials testing CAR-T in combination with targeted therapies.
Primary Specialty
Hematologist
GenderMale
EducationGeorgetown University School of Medicine (Doctoral Program)